CBD at this dose was associated with improved quality-of-life scores in a small exploratory Parkinson’s trial. Journal of Psychopharmacology
People in the UK are estimated to be diagnosed with Parkinson’s in their lifetime. Parkinson’s UK
Most people with Parkinson’s start to develop symptoms when they are over the age of 50. NHS
Could treatment be suitable?
A specialist may assess you if:
- You have a diagnosed condition or an established clinical history.
- Standard treatments have not helped enough or were unsuitable.
- You are 18 or over and live in the UK.
- Your records allow a doctor to review previous care and current medicines.
Understanding the condition
What is Parkinson’s disease?
Parkinson’s disease is a condition in which parts of the brain become progressively damaged over many years, reducing the production of a chemical called dopamine.
This loss of brain cells leads to symptoms such as tremors, slow movement and stiff, inflexible muscles. Symptoms are usually mild at first and gradually become more noticeable over time.
Recognising the impact
Common parkinson’s disease symptoms
Parkinson’s affects people differently, and symptoms develop gradually.
- Tremor, often starting in a hand or arm
- Slowness of movement
- Stiff and inflexible muscles
- Problems with balance and posture
- Disturbed sleep and fatigue
- Pain, anxiety or low mood
Conventional treatments
Conventional treatment options
Parkinson's is managed by specialists using medicines and therapies. Recognised options include:
- Levodopa combined with other medicines
- Dopamine agonists
- MAO-B inhibitors and COMT inhibitors
- Amantadine or apomorphine in selected cases
- Anticholinergics for specific symptoms where appropriate
- Physiotherapy, occupational therapy and speech and language therapy
Although these options help many people, they are not enough for everyone. If parkinson’s disease symptoms still affect daily life, a specialist assessment can help you understand whether another route may be suitable.
Specialist-led care
Can medical cannabis help with Parkinson's-related symptoms?
Medical cannabis is not a treatment for Parkinson's disease or its progression. Where certain symptoms such as stiffness, discomfort or sleep persist, a specialist may review whether it could help as part of wider care.
THC and CBD interact with the body’s endocannabinoid system, which is involved in movement, pain, sleep and mood. This is why researchers continue to study whether cannabis-based medicines may help with some Parkinson’s symptoms, such as pain, anxiety and sleep disturbance.
Where Parkinson’s-related symptoms continue to affect daily life, a doctor on the GMC Specialist Register reviews your diagnosis and current medicines to consider whether a prescription may be appropriate as part of your wider care. Effects can vary, so specialist guidance is key.
Effects can vary from person to person, which is why a GMC-registered specialist reviews your symptoms, goals, medicines and records before deciding whether treatment may be appropriate.
Eligibility screening
Tell us about your diagnosis, symptoms and treatments already tried. No GP referral is needed.
Specialist consultation
A GMC-registered specialist reviews your records, goals, current medicines and relevant risks by online video.
Decision and follow-up
When treatment is appropriate, outcomes and side effects are monitored and the plan is reviewed.
Evidence
What does the evidence say?
Developing evidence (symptom support)
Evidence on cannabis and Parkinson's disease is still developing and relates to symptom support rather than changing the condition itself. Research into cannabinoids in Parkinson's looks at symptoms such as sleep, pain, stiffness or anxiety, which a specialist reviews case by case.
- Levodopa and other recognised Parkinson's medicines remain the foundation of care.
- Evidence is still developing; it does not treat disease progression.
- Any role focuses on specific symptoms, reviewed individually.
Related support
Explore related parkinson’s disease support
These pages may help if symptoms overlap or you want to understand the wider specialist assessment pathway.
Safety
Possible side effects
Medical cannabis is prescribed under specialist supervision, and patient experience can vary. Your clinician will explain what to watch for and adjust your plan if needed.
- Decreased appetite or feeling sick
- Diarrhoea or weakness
- Dizziness or feeling very tired
- Behavioural or mood changes
They’ll usually ease on their own, but speak to your clinician if they don’t improve over time.
Questions
Parkinson’s Disease FAQs
Clear answers on eligibility, suitability and legal prescribing in the UK.
Is medical cannabis legal for Parkinson's-related symptoms in the UK?
Medical cannabis has been legal to prescribe in the UK since November 2018, but only a specialist doctor on the GMC Specialist Register can prescribe it, and only when it is clinically appropriate. Eligibility does not guarantee a prescription.
Can medical cannabis support Parkinson’s symptoms?
For some people, medical cannabis may help with specific symptoms when standard options have not provided enough relief. A specialist assesses your diagnosis and current medicines to decide whether a prescription is clinically appropriate, as effects can vary from person to person.
Is cannabis legal in the UK?
Prescription cannabis-based products for medicinal use have had a legal prescribing route in the UK since 1 November 2018. Recreational cannabis remains illegal, and a legal medicine must be prescribed for you and used exactly as directed.
Is an online assessment as reliable as in person?
Yes. Our structured video assessments follow the same recognised diagnostic standards used in face-to-face appointments, with the added convenience of being seen from home.
Do I need a GP referral?
No GP referral is needed to start an eligibility check. Sharing your medical records helps the specialist review your history and current medicines, and we can keep your GP informed if you wish.
Find out whether a specialist assessment may be suitable
Complete a short eligibility check. A prescribing decision can only be made after a full clinical assessment by a GMC-registered specialist.